Literature DB >> 33818752

Can shear wave elastography determine remnant thyroid tissue in the early postoperative period in patients with differentiated thyroid carcinoma?

Emine Uysal1, Gonca Kara Gedik2, Mehmet Sedat Durmaz3, Farise Yılmaz2, Abdussamed Batur3.   

Abstract

PURPOSE: This study aims to investigate the usability of ultrasonography (US) and shear wave elastography (SWE) in detecting remnant thyroid tissue (RTT) within the first three postoperative months in patients who underwent total thyroidectomy (TT) for differentiated thyroid cancer (DTC) and who were scheduled for radioiodine (RAI) ablation therapy.
METHODS: Sixty-nine patients who underwent a TT operation due to DTC were included in the study. The participant's thyroid surgical bed was first evaluated by thyroid scintigraphy and then by greyscale US and SWE to investigate RTT. The participants were divided into two groups, those with and those without RTT. SWE quantitative data were compared between the two groups. Receiver operating characteristic (ROC) curve analysis was performed to determine the best cut-off values for stiffness and velocity in distinguishing RTT.
RESULTS: A total of 149 regions were analysed in 69 participants (43 females, 26 males). The average time elapsed after the operation was 65.2 ± 24.1 days. RTT was determined by scintigraphy and US-SWE in 38 (55%) patients. The stiffness and velocity values were significantly higher in the group with RTT than in the group without RTT. To distinguish RTT from the thyroid bed, the best cut-off values for stiffness and velocity were 15.7 kPa and 2.12 m/s, respectively.
CONCLUSIONS: US with SWE can detect RTT in the early postoperative period in patients who have undergone TT due to DTC and who are scheduled for RAI treatment. The use of US and SWE will be particularly beneficial in patients with RTT but who have false-negative Tg levels and RTT that is not I-131 avid.
© 2021. Società Italiana di Ultrasonologia in Medicina e Biologia (SIUMB).

Entities:  

Keywords:  Differentiated thyroid cancer; Remnant thyroid tissue; Shear wave elastography; Total thyroidectomy; Ultrasonography

Mesh:

Substances:

Year:  2021        PMID: 33818752      PMCID: PMC9148334          DOI: 10.1007/s40477-021-00576-w

Source DB:  PubMed          Journal:  J Ultrasound        ISSN: 1876-7931


  37 in total

1.  Sonographic findings in the surgical bed after thyroidectomy: comparison of recurrent tumors and nonrecurrent lesions.

Authors:  Jung Hee Shin; Boo-Kyung Han; Eun Young Ko; Seok Seon Kang
Journal:  J Ultrasound Med       Date:  2007-10       Impact factor: 2.153

Review 2.  Normal and abnormal sonographic findings at the thyroidectomy sites in postoperative patients with thyroid malignancy.

Authors:  Myung-Su Ko; Jeong Hyun Lee; Young Kee Shong; Gyung Yub Gong; Jung Hwan Baek
Journal:  AJR Am J Roentgenol       Date:  2010-06       Impact factor: 3.959

3.  Diagnostic Accuracy Evaluation of Two-Dimensional Shear Wave Elastography in the Differentiation Between Benign and Malignant Thyroid Nodules: Systematic Review and Meta-analysis.

Authors:  Raimundo Holanda Carneiro Filho; Fernando Linhares Pereira; Wagner Iared
Journal:  J Ultrasound Med       Date:  2020-03-30       Impact factor: 2.153

Review 4.  A bump: what to do next? Ultrasound imaging of superficial soft-tissue palpable lesions.

Authors:  Orlando Catalano; Carlo Varelli; Carolina Sbordone; Antonio Corvino; Dario De Rosa; Gianfranco Vallone; Ximena Wortsman
Journal:  J Ultrasound       Date:  2019-11-30

5.  Postsurgical thyroid remnant estimation by (⁹⁹m) Tc-pertechnetate scintigraphy predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma.

Authors:  Luca Giovanella; Sergio Suriano; Riccardo Ricci; Luca Ceriani; Frederik Anton Verburg
Journal:  Head Neck       Date:  2010-09-07       Impact factor: 3.147

6.  Quantitative Assessment of Thyroid Glands in Healthy Children With Shear Wave Elastography.

Authors:  Emine Uysal; Mehmet Öztürk
Journal:  Ultrasound Q       Date:  2019-09       Impact factor: 1.657

7.  Postoperative-stimulated serum thyroglobulin measured at the time of 131I ablation is useful for the prediction of disease status in patients with differentiated thyroid carcinoma.

Authors:  Ji In Lee; Yun Jae Chung; Bo Youn Cho; SeMin Chong; Ju Won Seok; Sung Jun Park
Journal:  Surgery       Date:  2013-03-13       Impact factor: 3.982

8.  Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma.

Authors:  F Pacini; E Molinaro; M G Castagna; L Agate; R Elisei; C Ceccarelli; F Lippi; D Taddei; L Grasso; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  2003-08       Impact factor: 5.958

9.  Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.

Authors:  I D Hay; E J Bergstralh; J R Goellner; J R Ebersold; C S Grant
Journal:  Surgery       Date:  1993-12       Impact factor: 3.982

10.  Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.

Authors:  Kenichi Matsuzu; Kiminori Sugino; Katsuhiko Masudo; Mitsuji Nagahama; Wataru Kitagawa; Hiroshi Shibuya; Keiko Ohkuwa; Takashi Uruno; Akifumi Suzuki; Syunsuke Magoshi; Junko Akaishi; Chie Masaki; Michikazu Kawano; Nobuyasu Suganuma; Yasushi Rino; Munetaka Masuda; Kaori Kameyama; Hiroshi Takami; Koichi Ito
Journal:  World J Surg       Date:  2014-01       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.